Page last updated: 2024-12-11

himastatin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

himastatin: structure given in first source; isolated from cultured broth of Streptomyces hygroscopious [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

himastatin : A dimeric cyclohexadepsipeptide with formula C72H104N14O20. It is an antibiotic isolated from Streptomyces hygroscopicus and exhibits antitumor and antibacterial activity. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID85053967
CHEBI ID190009
MeSH IDM0181527

Synonyms (6)

Synonym
bmy40800
himastatin
bmy-40800
bmy 40800
(3r,3'r,4ar,4a'r,7s,7's,10r,10'r,12as,12a's,17br,17b'r,18as,18a's,21r,21'r,24s,24's)-3,3',17b,17b'-tetrahydroxy-10,10'-bis[(1s)-1-hydroxyethyl]-7,7'-bis(2-methylpropyl)-21,21',24,24'-tetra(propan-2-yl)-2,2',3,3',4,4',4a,4a',6,6',7,7',9,9',10,10',13,13',17
CHEBI:190009
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (44.44)18.2507
2000's1 (11.11)29.6817
2010's3 (33.33)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]